JULIE HENDERSON: Open Payments
NPI 1871864876 · MC KEE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$185 in 10 payments from 7 companies in 2025. Trend: 2023 $127 · 2024 $222 · 2025 $185
Food & beverage: $185
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| ABBVIE INC. | 1 | $16 |
| Gilead Sciences, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: CAPLYTA, Auvelity, XIFAXAN, BREZTRI, VRAYLAR, MOUNJARO.
Industry payments across KY — which companies pay providers there.
